Clinical Trial Update: Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating paliperidone extended-release in adults with schizophrenia who have duration of illness less than 10 years; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-06-05